About our service

The Colorectal team offer comprehensive care in the diagnosis, treatment and support for patients with both benign and malignant (cancer) conditions relating to the bowel.

The team consists of 5 consultant colorectal and general surgeons in alphabetical order:

  • Mr J Eccersley
  • Mr P Kumar
  • Mr P Thomas
  • Mr S Vakis
  • Naseem Waraich - Secretary Claire Chapman 01283 511511 ext: 4073
  • Ioannis Virlos - Secretary Claire Chapman 01283 511511 ext: 4073

The team is supported by specialist radiologists Dr S Khan and Dr V Kerekes, gastroenterologists Dr A Palejwala and Dr D Watmough, a visiting oncologist Dr M Keni, an Advanced Nurse Practitioner Ms G Wright and stomatherapists Ms C Charles and Ms S Chester. A weekly multidisciplinary meeting discusses all cancer patients and also reviews outcome data.

The team are pleased to use innovative techniques to make surgery safe and to shorten the length of stay. All the surgeons are trained in advanced laparoscopic (keyhole) surgery, and two-thirds of all elective operations for bowel cancer are completed laparoscopically.

The team have an established and effective enhanced recovery (ERAS) pathway with a median length of stay of 5 days after major resections. The team successfully introduced laparoscopic Extra-Levator Abdominoperineal Excision (ELAPE) and pelvic floor reconstruction for low rectal cancers.

The Burton team also offer a full range of diagnostic services including Colonoscopy, CT colonography, MRI scanning, Transrectal / endoanal ultrasonography and Anorectal Manometry. Therapeutic procedures available include laparoscopic resection, rectopexy, ileo-anal pouch reconstruction, colonic stenting, biofeedback and support for both retrograde and antegrade colonic irrigation.

A Burton Consultant Surgeon is an accredited bowel screening colonoscopist who provides screening endoscopy lists at the Regional Screening Hub in Derby. Patients with screen detected bowel cancers are repatriated to Burton for treatment.

The team participate in National Bowel Cancer audit and all surgeons consented to the publication of named surgeon data in the near future. Between April 2010 and March 2012 4 four patients died within 90 days of elective surgery; during this time approximately 151 patients had elective surgery for cancer. We calculate the unadjusted 90 day postoperative mortality as 2.7%, lower than the reported national average of 3.2%. All adverse outcomes after surgery are reviewed by the team. In these cases two patients died of heart attacks after surgery, despite appropriate pre-operative preparation. Two patients died some weeks after surgery as a result of frailty and the effects of their cancer.

Previous concerns about higher than average mortality rates after surgery in the years 1998-2004 led to an extensive review of the service by both the Royal College of Surgeons (RCS) and the National Cancer Action Team (NCAT) during 2012. The principle conclusion of the RCS report was that there was no cause for concern about mortality, and that surgical technique was good. The team met 90% of measures in NCAT Peer Review, a figure that is well above the national average and the team has some of the best compliance with cancer waiting times in the region.

  • GEM Going that extra mile
  • Top 40 Hospital Winner
  • NHS Choices
  • Urdu Polski
  • Burton Clinic